<DOC>
	<DOCNO>NCT03080194</DOCNO>
	<brief_summary>This 12-month single-arm study , include 6-month follow-up period 6-month interim analysis period . Patients schizophrenia violence risk government supervision enrol study . A community-based long-acting antipsychotics-treated management model apply studying subject , mean professional psychiatrist provide guidance primary-level mental health worker psychotic treatment , monthly-injected long-acting antipsychotic , paliperidone palmitate , use schizophrenia treatment . Every study subject equip intelligent robot capable push-to-talk push-to-view , allow patient caregiver contact doctor assistance time . The study subject inject 150mg eq 100mg eq paliperidone palmitate deltoid 1st 8th day , afterwards flexible dose paliperidone palmitate 75 150mg eq administrate monthly accord clinical judgement .</brief_summary>
	<brief_title>The Effect Community-based LAI-treated Management Model Violence Risk Patients With Schizophrenia</brief_title>
	<detailed_description>This 12-month single-arm study , include 6-month follow-up period 6-month interim analysis period . Patients schizophrenia violence risk government supervision enrol study . A community-based long-acting antipsychotics-treated management model apply studying subject , mean professional psychiatrist provide guidance primary-level mental health worker psychotic treatment , monthly-injected long-acting antipsychotic , paliperidone palmitate , use schizophrenia treatment . Studying subject equip intelligent robot capable push-to-talk push-to-view , allow patient caregiver contact doctor assistance time , able use smart phone . The study subject inject 150mg eq 100mg eq paliperidone palmitate deltoid 1st 8th day , afterwards flexible dose paliperidone palmitate 75 150mg eq administrate monthly accord clinical judgement . Previous oral antipsychotic could continue withdrawn 2-4 week first paliperidone palmitate administration accord doctor ' clinical judgement . Doctors right decide whether patient need in-hospital treatment extramural hospital treatment . The study protocol limit medication treatment measure except injectable paliperidone palmitate . Other medication treatment measure decide accord doctor ' clinical judgement negotiation patient guardian .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Paliperidone Palmitate</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<criteria>Diagnosed schizophrenia accord Diagnostic Statistical Manual Mental Disorders , Fifth Edition ( DSMV ) ; Rated 2 5 score Violence Risk Assessment Severe Psychiatric Patients baseline ; Living guardian caregiver ; Informed consent patient guardian ; Resulted negative urine pregnancy test female reproductive age ; female subject must take effective measure prevent pregnancy whole study postmenopausal . Patients suicidal ideation suicidal attempt within 12 month screen accord Columbia Suicide Severity Rating Scale ; Intravenous drug abuse Opioid dependence within 3 month screen ; Patients treatmentresistant schizophrenia ; Clozapine longacting injectable antipsychotic use within 3 month within 2 drug halflife period screen ; Patients severe unstable cardiovascular , respiratory , nervous system system diseases ; clinically significant abnormality laboratory examination ECG ; Communication difficulty cause cognitive impairment unable complete assessment study ; Patients assess unsuitable study reason , allergic intolerant risperidone paliperidone , resistant risperidone paliperidone ( ineffective adequate dosage duration medical history ) ; unable provide inform consent ; historical treatment might effect result study ; historical neuroleptic malignant syndrome tardive dyskinesia .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>schizophrenia</keyword>
	<keyword>violence risk</keyword>
	<keyword>long-acting antipsychotic</keyword>
	<keyword>community-based</keyword>
</DOC>